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Leishmaniasis remains a major health problem of the tropical and subtropical world. The visceral
form causes the most fatalities if left untreated. Dramatic increases in the rates of infection and drug
resistance and the non-availability of safe vaccines have highlighted the need for identification
of novel and inexpensive anti-leishmanial agents. This study reports that racemoside A, a
water-soluble steroidal saponin purified from the fruits of Asparagus racemosus, is a potent
anti-leishmanial molecule effective against antimonial-sensitive (strain AG83) and -unresponsive
(strain GE1F8R) Leishmania donovani promastigotes, with IC50 values of 1.15 and 1.31 mg ml
”1,
respectively. Incubation of promastigotes with racemoside A caused morphological alterations
including cell shrinkage, an aflagellated ovoid shape and chromatin condensation. This compound
exerts its leishmanicidal effect through the induction of programmed cell death mediated by the loss
of plasma membrane integrity as detected by binding of annexin V and propidium iodide, loss of
mitochondrial membrane potential culminating in cell-cycle arrest at the sub-G0/G1 phase, and
DNA nicking shown by deoxynucleotidyltransferase-mediated dUTP end labelling (TUNEL).
Racemoside A also showed significant activity against intracellular amastigotes of AG83 and
GE1F8R at a 7–8-fold lower dose, with IC50 values of 0.17 and 0.16 mg ml
”1, respectively, and was
non-toxic to murine peritoneal macrophages up to a concentration of 10 mg ml”1. Hence,
racemoside A is a potent anti-leishmanial agent that merits further pharmacological investigation.
INTRODUCTION
Leishmaniasis can occur in diverse clinical forms such as
cutaneous, mucosal and visceral leishmaniasis (VL, the
most severe) and remains a major health problem in the
tropics and subtropics, threatening almost 350 million
people in 88 countries (Chava et al., 2005; Murray et al.,
2005). Approximately 50% of the world’s cases of VL
occur in the Indian subcontinent (Desjeux, 2004). To date,
there are no vaccines against leishmaniasis and therefore
treatment relies on chemotherapy. The use of chemo-
therapy, especially in India, is unsatisfactory due to
increasing unresponsiveness to first-line treatment with
pentavalent antimonials (Sundar & Chatterjee, 2006).
These limitations also apply to amphotericin B and its
lipid formulations due to toxicity, high cost and the need
for parenteral administration (Guerin et al., 2002).
Miltefosine exhibited promise as the first oral candidate,
but a poor cost : benefit ratio and the possibility of the
development of resistance have restricted its potential
(Murray et al., 2005; Perez-Victoria et al., 2003), thus
highlighting the urgent need for new drugs.
Programmed cell death (PCD) mechanisms are known to
be operative in kinetoplastid parasites of the genus
Trypanosoma (Szallies et al., 2002) and Leishmania
(Arnoult et al., 2002) in response to various chemo-
therapeutic stimuli such as pentostam, amphotericin B
(Lee et al., 2002) and miltefosine (Paris et al., 2004).
Plant-derived products have shown promise in the search
for better therapeutics against leishmaniasis (Dupouy-
Camet, 2004). In this regard, the leaf exudate of Aloe vera
(Dutta et al., 2007a, b) and triterpenoid saponin of Careya
arborea (Mandal et al., 2006a) have been reported to be
leishmanicidal. Although water-insoluble saponins have
shown anti-leishmanial properties (Delmas et al., 2000;
Maes et al., 2004), to our knowledge, no leishmanicidal
activity mediated by PCD has been demonstrated.
Abbreviations: MFI, mean fluorescence intensity; PCD, programmed cell
death; PI, propidium iodide; SAG, sodium antimony gluconate; TdT,
terminal deoxynucleotidyltransferase; TUNEL, TdT-mediated dUTP end
labelling.
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The main objectives of the present study were to evaluate
the anti-leishmanial effect and putative mechanism(s) of a
water-soluble steroidal saponin, racemoside A, purified
from the fruits of Asparagus racemosus. Here, we report, for
the first time, that racemoside A is a potent anti-
leishmanial molecule against both promastigotes and
amastigotes of Leishmania donovani, acting by inducing
PCD.
METHODS
Materials. M199 medium and fetal calf serum (FCS) were obtained
from Gibco-BRL, DMSO from SRL, methanol from Merck and
5,59,6,69-tetrachloro-1,19, 3,39-tetraethylbenzimidazolylcarbocyanine
iodide (JC-1) and propidium iodide (PI) from Molecular Probes.
Annexin V–FITC and the ApoDirect kit were from BD Biosciences.
All other chemicals were from Sigma unless stated.
Parasite culture. Promastigotes were obtained from two Indian L.
donovani strains, AG83 (MHOM/IN/83/AG83) and GE1F8R (a
subclone of MHOM/IN/90/GE1) (Dutta et al., 2005). Based on their
clinical response to sodium antimony gluconate (SAG), they were
classified as SAG sensitive (AG83) or SAG resistant (GE1F8R). They
were routinely cultured at 22 uC in complete medium (M199
medium supplemented with 10% heat-inactivated FCS and 100 mg
gentamicin ml21).
Extraction, isolation and structure elucidation of racemoside A.
Racemoside A was purified from dried fruits of Asparagus racemosus
(Mandal et al., 2006b). The compound was characterized as (25S)-5b-
spirostan-3b-ol-3-O-{b-D-glucopyranosyl(1A6)-[a-L-rhamnopyranosyl
(1A6)-b-D-glucopyranosyl(1A4)]-b-D-glucopyranoside} with the
molecular formula C51H84O22 (Fig. 1). Racemoside A was dissolved
in RPMI 1640 at a concentration of 1 mg ml21 for evaluation of
its anti-leishmanial activity.
Anti-promastigote activity of racemoside A (in vitro).
Exponential-phase promastigotes of L. donovani AG83 and GE1F8R
were resuspended in modified RPMI 1640 (without phenol red)
supplemented with 10% FCS and 100 mg gentamicin ml21,
designated medium A. Parasites (26105) were seeded in 96-well
tissue culture plates (0.25 ml per well) and exposed to increasing
concentrations of racemoside A (0–10 mg ml21) or amphotericin B
(0–10 mg ml21) for 72 h at 22 uC. Parasite viability was evaluated
using a modified MTT assay, where the conversion of 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) to
formazan by mitochondrial enzymes served as an indicator of cell
viability and the amount of formazan produced was directly
proportional to the number of metabolically active cells (Dutta
et al., 2005). Accordingly, absorbance at 492 nm represented the
number of live cells. The concentration that decreased cell growth by
50% (IC50) was determined by graphic extrapolation.
Anti-leishmanial activity in a macrophage–amastigote model
(ex vivo). Murine peritoneal macrophages were lavaged using cold
medium A from the peritoneum of BALB/c mice following starch
induction (2% starch administered intraperitoneally, 2 ml per
mouse) and harvested in cold medium A. Cells (56105) were then
seeded on 16-well tissue culture glass slides (0.10 ml per well) and
allowed to adhere overnight in an atmosphere of 5% CO2 at 37 uC.
After removal of non-adherent macrophages, stationary-phase
promastigotes of strain AG83 were added to the macrophages at a
ratio of 5 : 1 (parasite : macrophage) and incubated overnight in the
same environment. Non-phagocytosed parasites were removed by
gentle washing and infected macrophages were incubated with
racemoside A (0–1 mg ml21) or amphotericin B (0–1 mg ml21) for
an additional 72 h. The slides were fixed in methanol and Giemsa
stained, and the number of amastigotes within macrophages was
determined microscopically. The number of parasites per 100 macro-
phages per well was determined from quadruplicate cultures and the
IC50 was established from the number of amastigotes in 100 macro-
phages. The ex vivo effect of racemoside A on the antimonial-resistant
strain GE1F8R was enumerated in a similar way.
In parallel, the toxic effect of racemoside A on murine peritoneal
macrophages was determined by incubating cells for 72 h in the
presence or absence of racemoside A (0–10 mg ml21) in medium A
and evaluating the viability of macrophages as above. The absorbance
by macrophages in the absence of racemoside A was considered to be
100%.
Analysis of promastigote cellular morphology. Morphological
changes in parasites as a result of racemoside A treatment were
identified microscopically. Briefly, exponential-phase promastigotes
were incubated in the absence (controls) or presence of racemoside A
(10 mg ml21) for 0–24 h in medium A. At various time points, cells
were centrifuged, fixed in 4% paraformaldehyde, attached to poly-L-
lysine-coated glass slides, mounted in glycerol and examined under a
confocal microscope (Leica). At least 20 microscope fields were
observed for each sample.
Analysis of externalized phosphatidylserine in promastigotes
by flow cytometry. Exponential-phase promastigotes were incubated
with racemoside A (10 mg ml21) for 0–6 h. Cells were centrifuged
(3000 g for 5 min), washed twice in PBS and resuspended in annexin
V binding buffer [10 mM HEPES/NaOH (pH 7.4), 140 mM NaCl,
2.5 mM CaCl2]. Annexin V–FITC and PI were then added according
to the manufacturers’ instructions, and incubated for 30 min in the
dark at 20–25 uC. Data acquisition was carried out on a FACSCalibur
flow cytometer (BD) and analysed using CELLQUEST software. If there
is an alteration of the membrane integrity (due to externalization of
phosphatidylserine), annexin V detects both pro- and late-apoptotic
cells. Therefore, the simultaneous addition of PI, which does not enter
healthy cells with an intact plasma membrane, discriminates between
pro-apoptotic (annexin V-positive and PI-negative), late-apoptotic
(both annexin V- and PI-positive), necrotic (PI-positive) and live
(both annexin V- and PI-negative) cells.
Fig. 1. Structure of racemoside A. Racemoside A was purified
from a methanol extract of air-dried powdered fruits of A.
racemosus. Elucidation of the structure was based on 1H and
13C NMR, distortionless enhancement by polarization transfer,
correlation spectroscopy, total correlation spectroscopy, nuclear
Overhauser effect spectroscopy, heteronuclear multiple-quantum
coherence and heteronuclear multiple-bond correlation experi-
ments. Glc, Glucose; Rha, rhamnose.
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Measurement of the mitochondrial membrane potential of
promastigotes. Mitochondrial damage was assessed using a cell-
permeable dye, JC-1, to analyse the change in mitochondrial
transmembrane potential (Dym). The carbocyanine dye JC-1 exists
as a monomer or as aggregates, depending on concentration and
membrane potential. In the mitochondria of healthy cells, with high
Dym, the dye spontaneously forms complexes, known as J-aggregates,
that emit red fluorescence at 585 nm. Following the onset of
apoptosis, as the mitochondrial potential decreases, JC-1 remains in
the monomeric form, emitting green fluorescence at 530 nm. Thus,
the ratio of red (585 nm) to green (530 nm) fluorescence represents
Dym, which is dependent only on the membrane potential (Reers
et al., 1995). After exposure to racemoside A (10 mg ml21) for 0–6 h,
exponential-phase promastigotes were centrifuged, resuspended in
PBS containing JC-1 (10 mg in 0.1 ml per well) and incubated at
37 uC for 10 min. Analysis of the mean green and red fluorescence
intensities was carried out using a FACSCalibur and CELLQUEST
software. The mitochondrial transmembrane potential was calculated
from the ratio of the mean fluorescence intensity (MFI) of J-
aggregates and monomers.
Analysis of the cell cycle. Exponential-phase promastigotes were
incubated for 0–24 h in the presence of racemoside A (10 mg ml21)
and then washed twice with PBS (pH 7.2). Cells were fixed in chilled
methanol by incubating for 3 min on ice and then resuspended in
0.5 ml PBS containing 0.5 mg PI and 50 mg RNase A and incubated
for 1 h in the dark at room temperature. Data acquisition was carried
out using a FACSCalibur and analysed using CELLQUEST software.
In situ detection of DNA fragmentation of promastigotes. DNA
fragmentation within the cell was analysed by terminal deoxynucleo-
tidyltransferase (TdT)-mediated dUTP end labelling (TUNEL) using
an Apo-Direct kit according to the manufacturer’s instructions.
Briefly, promastigotes were incubated with racemoside A (10 mg ml21
for 0, 18 or 24 h), washed twice in PBS (pH 7.2) and fixed in 1%
paraformaldehyde for 30 min. Cells were washed again in PBS and
incubated in chilled 70% ethanol for 30 min on ice. After washing,
these cells were allowed to react with TdT enzyme in reaction buffer
and stained with PI and dUTP–FITC. Finally, cells were resuspended
in PBS before data acquisition using a FACSCalibur and CELLQUEST
software.
Statistical analysis. In vitro anti-leishmanial activity was expressed
as IC50 values by linear regression analysis. Values were determined as
means±SD from at least three independent experiments in duplicate.
P values were estimated using Student’s t-test.
RESULTS AND DISCUSSION
Racemoside A-mediated death in L. donovani
promastigotes
The viability of promastigotes after treatment with
racemoside A was evaluated using a modified MTT assay.
MTT is converted to formazan by active mitochondrial
enzymes. Therefore, a decrease in formazan production
indicates a reduction in the number of metabolically active
cells, i.e. a decrease in cell viability. Treatment of promas-
tigotes with racemoside A demonstrated a dose-dependent
inhibition of parasite growth irrespective of SAG sensitiv-
ity. IC50 values in the SAG-sensitive strain AG83 and SAG-
resistant strain GE1F8R promastigotes were 1.15 and
1.31 mg ml21, respectively (Fig. 2a). The established
anti-leishmanial drug amphotericin B, used as a positive
control, showed a similar trend in dose-dependent parasite
killing, with IC50 values of 0.17 and 0.22 mg ml
21 for AG83
and GE1F8R, respectively.
Saponins comprise a large group of compounds known for
their ability to permeate cells. However, the concentration
required (1 mg ml21) is ~100-fold higher than that
required for racemoside A (10 mg ml21). Anti-leishmanial
activity of a water-insoluble triterpenoid saponin isolated
from C. arborea has been reported against L. donovani
promastigotes, with an IC50 of 15 mg ml
21 (Mandal et al.,
2006a), but its effect against the intracellular form of the
parasite (amastigotes) has yet to be elucidated. Similarly,
water-insoluble sapogenin from Asparagus africanus was
parasiticidal (IC50 31±4 mg ml
21) against Leishmania
major promastigotes (Oketch-Rabah et al., 1997). How-
ever, this sapogenin has not been tested against VL-causing
forms of Leishmania such as L. donovani, which cause the
most fatalities. Racemoside A has sugar moieties attached
to the core structure and this core structure is similar to the
structure of sapogenin. Our data demonstrated that
racemoside A, a unique water-soluble steroidal saponin,
is much more active against L. donovani promastigotes
(IC50 1.15–1.31 mg ml
21; Fig. 2a) than is the water-
insoluble sapogenin (IC50 31±4 mg ml
21). Therefore, it
can be envisaged that these additional sugar molecules not
only increase the compound’s hydrophilicity, but also
enhance its leishmanicidal efficacy. Triterpenoid saponins
isolated from Maesa balansae showed anti-leishmanial
efficacy against L. donovani and Leishmania infantum at
very low doses, with IC50 values of 7–40 ng ml
21
(Germonprez et al., 2005; Maes et al., 2004). Unfor-
tunately, unlike racemoside A, these triterpenoid saponins
are water-insoluble. To our knowledge, this is the first
report of the leishmanicidal efficacy of a naturally
occurring, water-soluble, steroidal saponin.
Racemoside A-mediated death of L. donovani
amastigotes
Treatment with racemoside A demonstrated a dose-
dependent removal of phagocytosed amastigotes (Fig. 2b),
as shown by microscopic observation of Giemsa-stained
cells. The IC50 of racemoside A in amastigotes was 0.17 mg
ml21 in strain AG83 and 0.16 mg ml21 in strain GE1F8R,
which is comparable to the IC50 of amphotericin B, used as
a reference compound, with an IC50 of 0.16 mg ml
21
against AG83. The cytotoxic effect of racemoside A against
murine peritoneal macrophages was enumerated bio-
chemically using an MTT assay. The viability of murine
peritoneal macrophages was .92% after treatment with
racemoside A (1 mg ml21; Fig. 2c). A similar degree of
macrophage viability (.89%) was observed up to a
concentration of 10 mg racemoside A ml21.
Racemoside A is thus highly potent at very low doses, even
against the intracellular form of the parasite, i.e. approxi-
mately 7-fold more effective (IC50 0.16–0.17 mg ml
21)
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against amastigotes than against promastigotes, which was
comparable with the effect of amphotericin B (IC5050.16 mg
ml21; Fig. 2b). More importantly, the absence of shared
toxicity towards murine peritoneal macrophages, even up to
a concentration of 10 mg ml21 (Fig. 2c), increases its
therapeutic ratio (the ratio between leishmanicidal concen-
tration and the concentration that is toxic to host cells). The
efficacy of racemoside A against intra-macrophage amasti-
gotes (IC50 0.17 mg ml
21) was found to be higher than that
of known anti-leishmanial compounds such as Pentostam
(IC50 4.9–50 mg ml
21), miltefosine (IC50 13.6 mM; Paris
et al., 2004), SAG (IC50 154 mg ml
21; Roberts & Rainey,
1993) and lipid formulations of amphotericin B (IC50
0.2–2.6 mg ml21; Yardley & Croft, 2000), but comparable
to amphotericin B (IC50 0.013–0.18 mg ml
21; Yardley &
Croft, 2000). Higher leishmanicidal efficacy (low IC50),
solubility in water and less shared toxicity towards
mammalian cells (even at 10 mg ml21) make this readily
available plant-derived compound a potent anti-leishma-
nial molecule for SAG-sensitive and -resistant strains and
their amastigote forms, and thus it merits further
pharmacological investigation.
Racemoside A causes changes in promastigote
morphology
During PCD, the promastigotes alter to an ovoid shape
with nuclear condensation, which is accompanied by the
formation of fragmented nuclei (Sen et al., 2004). Phase-
contrast microscopic studies on the morphology of
racemoside A-treated L. donovani promastigotes demon-
strated the induction of certain morphological changes that
were similar to the signs of PCD. The flagellated
promastigotes shrank and became aflagellated and oval or
round with an increase in vacuoles as a result of
racemoside A exposure. The nuclei of control promasti-
gotes displayed a prominent central or slightly eccentrically
localized nucleolus, whilst chromatin was usually distrib-
uted peripherally beneath the nuclear membrane (Fig. 3).
However, in most of the treated cells, condensed, irregular,
bead-like, marginated chromatin and a fragmented nucleus
with condensed cytoplasm were observed (Fig. 3).
Fig. 2. (a) Analysis of the anti-promastigote activity of racemoside
A. Exponential-phase promastigotes (5104) of strains AG83 (#)
and GE1F8R ($) in 0.25 ml per well were incubated with
increasing concentrations of racemoside A (0–10 mg ml”1) for
72 h and a modified MTT assay was performed as described in
Methods. Promastigotes of AG83 (g) and GE1F8R (m) were
treated with amphotericin B (0–10 mg ml”1) as an experimental
control and evaluated similarly. Each point corresponds to the
mean±SD of at least three experiments in duplicate. (b) Evaluation
of the anti-amastigote activity of racemoside A. Murine peritoneal
macrophages were infected overnight with stationary-phase
promastigotes (at a ratio of 1 : 5) of AG83 (#) and GE1F8R
(&). After removal of non-phagocytosed parasites, infected
macrophages were incubated with increasing concentrations of
racemoside A (0–1 mg ml”1) for 72 h and the degree of parasite
removal was analysed microscopically from Giemsa-stained slides
as described in Methods. Leishmania-infected macrophages (g)
were treated with amphotericin B (0–1 mg ml”1) as an experi-
mental control and evaluated similarly. Each point corresponds to
the mean±SD of at least three experiments in duplicate. (c)
Evaluation of the macrophage toxicity of racemoside A. Murine
peritoneal macrophages were isolated and adhered overnight to
16-well glass slides in an atmosphere of 5% CO2 at 37 6C. After
removal of non-adherent cells, racemoside A (0–10 mg ml”1) was
added and the cells were incubated under similar conditions for
72 h. Cell viability was evaluated using a modified MTT assay as
described in Methods. Each point corresponds to the mean±SD of
at least three experiments in duplicate.
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Racemoside A-treated promastigotes show both
annexin V and PI binding
Translocation of phosphatidylserine from the inner side to
the outer layer of the plasma membrane is a common
alteration during PCD (Koonin & Aravind, 2002; Mehta &
Shaha, 2004). Annexin V, a Ca2+-dependent phospho-
lipid-binding protein with a special affinity for phos-
phatidylserine, is a general reagent used to detect the
externalization of phosphatidylserine, thus labelling cells
that have lost their membrane integrity.
Accordingly, in order to determine whether racemoside A
triggered cell death following a similar phenomenon,
promastigotes treated with racemoside A (10 mg ml21 for
0–6 h) were double-stained with annexin V–FITC and PI.
The percentage of racemoside A-treated promastigotes that
were positive only for annexin V gradually decreased from
11.52% after 30 min to ,1.0% after 1 h (Fig. 4).
However, the number of cells that were both annexin V-
and PI-positive (Fig. 4, upper-right quadrant) gradually
increased, to 2.54±1.05, 47.01±2.07 and 76.13±0.89%
at 15 min, 30 min and 1 h, respectively, indicating
late-apoptotic phase. A gradual decrease in these annexin
V- and PI-positive cells was observed at 4 and 6 h of
treatment, to 50.86±3.28 and 38.33±4.28%, respectively,
with a simultaneous increase in the percentage of necrotic
cells (annexin V-negative and PI-positive; Fig. 4, upper-left
quadrant), to 41.59±2.45% and 52.59±2.08%, respect-
ively. This was due to degradation of the parasites. These
observations suggested that racemoside A induced cell death
by loss of membrane integrity, as shown by the increased PI
incorporation and annexin V binding, indicating late-
apoptotic phase. In contrast, only 0.75±0.08% of untreated
cells were annexin V- and PI-positive, and the number of
cells positive for PI only was negligible at all time points
(0.07±0.02%).
To analyse the pro-apoptotic stage, promastigotes were
also incubated with a dose near the IC50 value (1.3 mg ml
21)
of racemoside A for 30 min, after which 8.26±2.02% cells
were positive for annexin V. At lower doses and with a
shorter duration (30 min) of exposure, a dose-dependent
increase in the number of cells positive for both annexin V
and PI was observed in all experimental sets, being 2, 7.77
and 16.88% at concentrations of 1.3, 2.5 and 5.0 mg ml21,
respectively. This indicated that this steroidal saponin is a
membrane-attacking molecule for L. donovani promasti-
gotes, suggesting that racemoside A acts directly on the
plasma membrane, making it leaky and thus driving PCD
signals.
Racemoside A induces sustained depolarization
of mitochondrial membrane potential
The mitochondrial membrane potential (Dym) is com-
monly determined by the ratio of red : green fluorescence at
585 and 530 nm, i.e. J-aggregates in mitochondria versus
monomers in the cytosol, using JC-1 staining (Reers et al.,
1995; Sen et al., 2004). Incubation of promastigotes with
racemoside A (10 mg ml21) for 3 h caused depolarization,
shown by a 16.49% decrease in the 585 : 530 ratio in cells
incubated in the presence of racemoside A compared with
unexposed cells (Fig. 5; 11.34±0.35 vs 13.58±0.39,
P,0.05). By 4 h, the decrease was 18.25% (Fig. 5;
11.11±0.51 vs 13.59±0.59) and this was sustained up to
5 h. A maximum decrease of 32.64% was observed at 6 h
(Fig. 5; 9.12±0.37 vs 13.54±0.53, P,0.02). Taken
together, these results indicated that exposure to racemo-
side A caused sustained mitochondrial membrane depol-
arization for up to 6 h, which may be due to imperfect
mitochondrial function.
Similarly, treatment of promastigotes with racemoside A
disturbed normal mitochondrial function as shown by the
reduction in formazan formation in an MTT assay due to
reduced mitochondrial dehydrogenases (Fig. 2a). The
reduction in formazan formation served as a measure of
the decrease in the number of viable cells and was also
associated with a decrease in mitochondrial membrane
potential, corroborated by the decreased red fluorescence
Fig. 3. Analysis of the cellular morphology of racemoside A-
treated promastigotes. Exponential-phase promastigotes (5104
in 0.25 ml per well) of strain AG83 were incubated with increasing
concentrations of racemoside A (0–10 mg ml”1) for 18 and 24 h,
fixed in 4% paraformaldehyde, adhered to poly-L-lysine-coated
glass slides and analysed by confocal microscopy as described in
Methods. Changes in chromatin following racemoside A treatment
are indicated by arrows. Bars, 30 mm (left panels), 7 mm (right
panels).
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of racemoside A-treated promastigotes following JC-1
staining (Fig. 5). This change in mitochondrial membrane
potential appeared to occur more slowly than the PI/
annexin V double staining at 3 h, when the majority of
cells were already in the late-apoptotic phase. The cells are
driven into the late-apoptotic phase by changes in the
morphology of the cell membrane, which thus initiates the
cascade of events involving the cell organelles (such as
mitochondria) leading to PCD. Most probably, racemoside
A directly targets the plasma membrane making it leaky
and this in turn switches on the mitochondria-mediated
death signal cascades. The depolarization is known to
commit cells to DNA fragmentation (Sen et al., 2004).
Racemoside A causes cell-cycle arrest in
L. donovani promastigotes
Treatment of promastigotes with racemoside A
(10 mg ml21) for 6, 18 and 24 h caused cell-cycle arrest
at the sub-G0/G1 phase, as analysed by flow cytometry. The
proportions of cells in this phase at these time points were
5.04, 8.06 and 15.33% compared with 1.61, 0.65 and
1.58%, respectively, for cells that were not exposed to
racemoside A (Fig. 6). This suggests that a check in the cell
cycle could initiate late events of PCD such as nuclear
condensation and DNA nicking. However, at 2 h, the
proportion of cells in different phases of the cell cycle was
comparable in both sets. This finding indicated that
nuclear changes are switched on by alterations in the cell
membrane and mitochondria and therefore can be
considered as a relatively late phase of PCD.
Fig. 4. Externalization of phosphatidylserine in racemoside A-treated promastigotes. Exponential-phase promastigotes of strain
AG83 were incubated with racemoside A (10 mg ml”1) for 0 (Control), 15 and 30 min and 1, 4 and 6 h, co-stained with PI and
annexin V–FITC and analysed by flow cytometry as described in Methods. The results show a representative profile of at least
three experiments.
Fig. 5. Changes in mitochondrial membrane potential following
treatment with racemoside A. Exponential-phase promastigotes of
strain AG83 were incubated with racemoside A (10 mg ml”1) for
0–6 h at 22 6C in complete medium (filled bars). Cells without
racemoside treatment were used as a negative control (open bars).
Cells were washed in PBS and probed with JC-1 (10 mg in 0.1 ml
per well) and analysed by flow cytometry as described in Methods.
The ratio of fluorescence at 585 and 530 nm [i.e. J-aggregates
(red) in the mitochondria vs monomers (green) in the cytosol]
represents Dym. Each bar corresponds to the mean±SD of at least
three experiments in duplicate.
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Oligonucleosomal DNA fragmentation in
racemoside A-treated promastigotes
One of the hallmarks of apoptotic cell death is the
degradation of nuclear DNA into nucleosomal units.
DNA nicking resulting from exposure to racemoside A
was detected using a TUNEL assay in which the proportion
of DNA nicks was quantified by measuring the binding of
dUTP–FITC to the nicked ends via TdT. Thus, the
proportion of DNA nicks was directly proportional to
the fluorescence obtained from dUTP–FITC.
The treatment of promastigotes with racemoside A (10 mg
ml21) demonstrated a time-dependent increase in nuclear
DNA fragmentation as shown by dUTP–FITC binding
(Fig. 7). After 18 h of treatment, the degree of DNA
nicking (MFI59.05) was marginally increased compared
with untreated promastigotes (MFI56.91), which served
as a control. However, after 24 h, the degree of DNA
nicking was amplified (MFI519.41) and the percentage of
Fig. 6. Analysis of the cell-cycle status of racemoside A-treated promastigotes. Exponential-phase promastigotes of strain
AG83 were incubated with racemoside A (10 mg ml”1) for 2, 6, 18 and 24 h, fixed in chilled methanol, probed with PI and
analysed using a FACSCalibur and CELLQUEST software as described in Methods.
Fig. 7. Analysis of TUNEL positivity in racemoside A-treated
promastigotes. Exponential-phase promastigotes of strain AG83
were incubated with racemoside A (10 mg ml”1) for 0 h (a), 18 h
(b) and 24 h (c). Cells were fixed, stained with PI and dUTP–FITC
in the presence of TdT and RNase enzyme and analysed by flow
cytometry as described in Methods.
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dUTP–FITC-positive cells increased to 23.07% compared
with 4.28% of untreated cells (ethanol-fixed mammalian
cell populations, supplied in the kit, served as positive and
negative controls; data not shown).
DNA nicking in promastigotes strongly suggests that the
leishmanicidal effect is mediated by PCD. Cells were
positive for both annexin V and PI at early time points,
indicating that racemoside A directly targets the plasma
membrane, making it more fragile and subsequently
switching on mitochondria-mediated death signal cascades
(Fig. 4). This signal was orchestrated by a substantial
depolarization (~32.64%) of the mitochondrial membrane
after 6 h (Fig. 5), chromatin condensation (Fig. 3), cell-
cycle arrest at the sub-G0/G1 phase after 24 h (Fig. 6) and
TUNEL positivity after 24 h (Fig. 7).
In this study, we have shown for the first time that a newly
identified, water-soluble, natural steroidal saponin, race-
moside A (Fig. 1), had a leishmanicidal effect against
promastigotes of both an SAG-sensitive and an SAG-
unresponsive strain (Fig. 2a). This anti-leishmanial activity
was almost seven times higher against intracellular amasti-
gotes (Fig. 2b), with a high therapeutic ratio (Fig. 2c),
making it a potent candidate for future chemotherapy.
Thus, we have conclusively demonstrated the leishmanici-
dal effect of racemoside A-induced PCD as shown by a
number of biochemical and morphological techniques
including annexin V and PI co-staining, changes in
mitochondrial membrane potential, cell-cycle arrest and
in situ DNA nicking. This study widens the scope for the
design of new chemotherapeutic agents for better manage-
ment of this disease.
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